WaratekVRT Sign in

Oracle Health Sciences Applications Platform CVEs

4 CVEs

Reset
More filters (1)
Columns
Oracle product: Oracle Health Sciences Applications / Platform✕
Overview 4 matches · 0 protected · 0 exploited · 0 CISA KEV · 0 public PoC · 0 EPSS ≥ 0.5
4matches 0protected0.0% 0exploited0.0% 0CISA KEV0.0% 0public PoC0.0% 0EPSS ≥ 0.50.0%
Protected by Waratek 0 0.0% Rule in development 0 0.0% Mitigation candidate 0 0.0% No exploit published 4 100.0%
Critical 0 0.0% High 0 0.0% Medium 4 100.0% Low 0 0.0% None 0 0.0% Unknown 0 0.0%
blocked by ARMR today 0 0.0% partly blocked 0 0.0% not blocked 4 100.0% not established 0 0.0% unrecorded 0 0.0%
Exploited 0 0.0% Working exploit published 0 0.0% Proof of concept only 0 0.0% Forecast only 0 0.0% No public exploit 4 100.0%
split by peak 4 / month
No exploit published: 4 Medium: 4 not blocked: 4 No public exploit: 4
Jan 264 No exploit published4 Medium4 not blocked4 No public exploit4
Jan 26
4 matches Sign in to download these CVEs as CSV or JSON, or to follow them in a feed.
CVE Severity Published▾ Status Exploitation Description
CVE-2026-21980 Medium 2026-01-20 No exploit published No public exploit Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CVE-2026-21974 Medium 2026-01-20 No exploit published No public exploit Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
CVE-2026-21970 Medium 2026-01-20 No exploit published No public exploit Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
CVE-2026-21923 Medium 2026-01-20 No exploit published No public exploit Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).